W R Porter|W F Trager - JoVE Visualize

Showing results (81-90 of 102) with videos related to

Pageof 11

Sort By:

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1983

Adsorption of insulin to the surface of peritoneal dialysis solution containersC A Johnson, G Amidon, J E Reichert, et al.

Neurotoxicology|January 1, 1983

Effects of dose and dosing regimen on tissue distribution and elimination kinetics of [14C] dithiobiuret in ratsW R Porter, J Dickins, W D Atchison, et al.

Steroids|February 1, 1980

Carbon-13 nuclear magnetic resonance studies of spironolactone and several related steroidsR J Highet, T R Burke, W F Trager, et al.

Clinical Pharmacology and Therapeutics|April 1, 1992

The mechanism of the interaction between amiodarone and warfarin in humansL D Heimark, L Wienkers, K Kunze, et al.

Biochemistry|March 17, 1999

Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin bindingR L Haining, J P Jones, K R Henne, et al.

The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 1, 1992

Effects of tannic acid on antigenicity and membrane contrast in ultrastructural immunocytochemistryM A Berryman, W R Porter, R D Rodewald, et al.

Journal of Pharmaceutical and Biomedical Analysis|January 1, 1984

Chemical and statistical considerations in the determination of partition coefficients of weakly ionizable drugs and poisonsK Opong-Mensah, T W Woller, A O Obaseki, et al.

Journal of Clinical Pharmacology|March 20, 1998

Lack of effect of azelastine and ketoconazole coadministration on electrocardiographic parameters in healthy volunteersJ Morganroth, W H Lyness, J L Perhach, et al.

Clinical Pharmacology and Therapeutics|September 1, 1993

Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by (S)-warfarin is not enhanced in cystic fibrosisT A O'Sullivan, J P Wang, J D Unadkat, et al.

Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|March 1, 1996

Chemical safety of U.S. Navy Fleet soda limeR S Lillo, A Ruby, D D Gummin, et al.

Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:

Pageof 11

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 1, 1983

Adsorption of insulin to the surface of peritoneal dialysis solution containersC A Johnson, G Amidon, J E Reichert, et al.

Neurotoxicology|January 1, 1983

Effects of dose and dosing regimen on tissue distribution and elimination kinetics of [14C] dithiobiuret in ratsW R Porter, J Dickins, W D Atchison, et al.

Steroids|February 1, 1980

Carbon-13 nuclear magnetic resonance studies of spironolactone and several related steroidsR J Highet, T R Burke, W F Trager, et al.

Clinical Pharmacology and Therapeutics|April 1, 1992

The mechanism of the interaction between amiodarone and warfarin in humansL D Heimark, L Wienkers, K Kunze, et al.

Biochemistry|March 17, 1999

Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin bindingR L Haining, J P Jones, K R Henne, et al.

The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|June 1, 1992

Effects of tannic acid on antigenicity and membrane contrast in ultrastructural immunocytochemistryM A Berryman, W R Porter, R D Rodewald, et al.

Journal of Pharmaceutical and Biomedical Analysis|January 1, 1984

Chemical and statistical considerations in the determination of partition coefficients of weakly ionizable drugs and poisonsK Opong-Mensah, T W Woller, A O Obaseki, et al.

Journal of Clinical Pharmacology|March 20, 1998

Lack of effect of azelastine and ketoconazole coadministration on electrocardiographic parameters in healthy volunteersJ Morganroth, W H Lyness, J L Perhach, et al.

Clinical Pharmacology and Therapeutics|September 1, 1993

Disposition of drugs in cystic fibrosis. V. In vivo CYP2C9 activity as probed by (S)-warfarin is not enhanced in cystic fibrosisT A O'Sullivan, J P Wang, J D Unadkat, et al.

Undersea & Hyperbaric Medicine : Journal of the Undersea and Hyperbaric Medical Society, Inc|March 1, 1996

Chemical safety of U.S. Navy Fleet soda limeR S Lillo, A Ruby, D D Gummin, et al.

Pageof 11